Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Medcomm|June 19, 2023
Preclinical characterization of WB737, a potent and selective STAT3 inhibitor, in natural killer/T-cell lymphomaYali Wang, Wenbo Zhou, Jianfeng Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 16, 2024
CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian CancerShini Liu, Peng Deng, Zhaoliang Yu, et al.
JCI Insight|June 6, 2024
4EBP1-mediated SLC7A11 protein synthesis restrains ferroptosis triggered by MEK inhibitors in advanced ovarian cancerJiaxin Yin, Jianfeng Chen, Jing Han Hong, et al.
Oncogene|May 23, 2024
Targeting AURKA to induce synthetic lethality in CREBBP-deficient B-cell malignancies via attenuation of MYC expressionYichen Sun, Jianfeng Chen, Jing Han Hong, et al.
Cancer Letters|June 22, 2024
CDK4/6 inhibition augments anti-tumor efficacy of XPO1 inhibitor selinexor in natural killer/T-cell lymphomaYali Wang, Jianfeng Chen, Yan Gao, et al.
Cancer Discovery|October 15, 2025
Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed/Refractory NK/T-cell LymphomaCheng Huang, Yan Gao, Jianfeng Chen, et al.
EMBO Molecular Medicine|August 9, 2024
Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerabilityPeiyong Guan, Jianfeng Chen, Chengqiang Mo, et al.
Gut|December 5, 2023
Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologiesJing Han Hong, Chern Han Yong, Hong Lee Heng, et al.
Science Translational Medicine|April 1, 2026
Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancersJing Han Hong, Chern Han Yong, Hong Lee Heng, et al.
Pageof 11